{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:22:31Z","timestamp":1792466551291,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004076","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000}}],"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Accurate routine HIV viral load testing is essential for assessing the efficacy of antiretroviral treatment (ART) regimens and the emergence of drug resistance. While the use of plasma specimens is the standard for viral load testing, its use is restricted by the limited ambient temperature stability of viral load biomarkers in whole blood and plasma during storage and transportation and the limited cold chain available between many health care facilities in resource-limited settings. Alternative specimen types and technologies, such as dried blood spots, may address these issues and increase access to viral load testing; however, their technical performance is unclear. To address this, we conducted a meta-analysis comparing viral load results from paired dried blood spot and plasma specimens analyzed with commonly used viral load testing technologies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>Standard databases, conferences, and gray literature were searched in 2013 and 2018. Nearly all studies identified (60) were conducted between 2007 and 2018. Data from 40 of the 60 studies were included in the meta-analysis, which accounted for a total of 10,871 paired dried blood spot:plasma data points. We used random effects models to determine the bias, accuracy, precision, and misclassification for each viral load technology and to account for between-study variation. Dried blood spot specimens produced consistently higher mean viral loads across all technologies when compared to plasma specimens. However, when used to identify treatment failure, each technology compared best to plasma at a threshold of 1,000 copies\/ml, the present World Health Organization recommended treatment failure threshold. Some heterogeneity existed between technologies; however, 5 technologies had a sensitivity greater than 95%. Furthermore, 5 technologies had a specificity greater than 85% yet 2 technologies had a specificity less than 60% using a treatment failure threshold of 1,000 copies\/ml. The study\u2019s main limitation was the direct applicability of findings as nearly all studies to date used dried blood spot samples prepared in laboratories using precision pipetting that resulted in consistent input volumes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This analysis provides evidence to support the implementation and scale-up of dried blood spot specimens for viral load testing using the same 1,000 copies\/ml treatment failure threshold as used with plasma specimens. This may support improved access to viral load testing in resource-limited settings lacking the required infrastructure and cold chain storage for testing with plasma specimens.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004076","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T17:42:41Z","timestamp":1661190161000},"page":"e1004076","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-1012","authenticated-orcid":true,"given":"Lara","family":"Vojnov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6792-4748","authenticated-orcid":true,"given":"Sergio","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-0336","authenticated-orcid":true,"given":"Clement","family":"Zeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Markby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debrah","family":"Boeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-731X","authenticated-orcid":true,"given":"Marta R.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-6340","authenticated-orcid":true,"given":"Anthony L. H.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-4454","authenticated-orcid":true,"given":"Souleymane","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Adje-Toure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3554-8124","authenticated-orcid":true,"given":"Mercedes","family":"Perez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-7129","authenticated-orcid":true,"given":"Meg","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-0991","authenticated-orcid":true,"given":"Chunfu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor F.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6047-0184","authenticated-orcid":true,"given":"John","family":"Nkengasong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DBS for VL Diagnostics Investigation Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"pmed.1004076.ref001","article-title":"Ending AIDS: Progress towards the 90-90-90 targets.","author":"UNAIDS","year":"2017"},{"key":"pmed.1004076.ref002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"pmed.1004076.ref003","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(00)04331-2","article-title":"Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai","volume":"357","author":"RH Gray","year":"2001","journal-title":"Uganda. Lancet"},{"key":"pmed.1004076.ref004","first-page":"1941","article-title":"Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.","volume":"17","author":"RH Gray","year":"2003","journal-title":"IDS"},{"issue":"10189","key":"pmed.1004076.ref005","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.","volume":"393","author":"A Rodger","year":"2019","journal-title":"Lancet"},{"key":"pmed.1004076.ref006","first-page":"41","article-title":"Expanded Highly Active Antiretroviral Therapy Coverage\u2014A Powerful Strategy to Curb Progression to AIDS, Death and New Infections.","volume":"3","author":"A Anema","year":"2009","journal-title":"Eur Infect Dis"},{"key":"pmed.1004076.ref007","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e32832e05b2","article-title":"Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.","volume":"23","author":"ART-LINC of IeDEA Group","year":"2009","journal-title":"AIDS"},{"key":"pmed.1004076.ref008","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1089\/088922200414965","article-title":"Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis","volume":"16","author":"HIV Surrogate Marker Collaborative Group","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pmed.1004076.ref009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513823","article-title":"Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy","volume":"177","author":"IC Marschner","year":"1998","journal-title":"J Infect Dis"},{"key":"pmed.1004076.ref010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma","volume":"272","author":"JW Mellors","year":"1996","journal-title":"Science"},{"key":"pmed.1004076.ref011","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00002030-199905070-00008","article-title":"The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs","volume":"13","author":"JS Murray","year":"1999","journal-title":"AIDS"},{"key":"pmed.1004076.ref012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0b013e318227fc34","article-title":"Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.","volume":"58","author":"KC Sigaloff","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref013","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200005260-00008","article-title":"Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d\u2019Epid\u00e9miologie du SIDA en Aquitaine (GECSA)","volume":"14","author":"R Thi\u00e9baut","year":"2000","journal-title":"AIDS"},{"key":"pmed.1004076.ref014","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/600396","article-title":"Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings","volume":"49","author":"R Kantor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"pmed.1004076.ref015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-3156.2009.02338.x","article-title":"Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy","volume":"14","author":"O Keiser","year":"2009","journal-title":"Trop Med Int Health"},{"key":"pmed.1004076.ref016","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAI.0b013e318186eb18","article-title":"CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.","volume":"49","author":"DM Moore","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref017","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cir729","article-title":"Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings","volume":"53","author":"HE Rawizza","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pmed.1004076.ref018","author":"World Health Organization","year":"2013","journal-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach"},{"key":"pmed.1004076.ref019","unstructured":"Abravaya K, Huang S, Erickson B, Mak WB. The use of dried blood spots with the Abbott RealTime HIV-1 viral load assay. XVII International AIDS Conference: Abstract no. CDB0034; Mexico City, Mexico: 2008."},{"key":"pmed.1004076.ref020","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/JCM.03305-12","article-title":"Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots","volume":"51","author":"S Aitken","year":"2013","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref021","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.arcmed.2005.03.010","article-title":"High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions","volume":"36","author":"MT Alvarez-Mu\u00f1oz","year":"2005","journal-title":"Arch Med Res"},{"key":"pmed.1004076.ref022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jcv.2009.11.006","article-title":"Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.","volume":"47","author":"M Andreotti","year":"2010","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref023","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/JCM.00418-11","article-title":"Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated Abbott Real-Time viral load assay","volume":"50","author":"M Arredondo","year":"2012","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref024","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JCM.01919-06","article-title":"Use of dried spots of whole blood, plasma, and mother\u2019s milk collected on filter paper for measurement of Human Immunodeficiency Virus Type 1 burden","volume":"45","author":"W Ayele","year":"2007","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref025","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/JCM.41.5.1888-1893.2003","article-title":"Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for Human Immunodeficiency Virus RNA: measurement, precision, and RNA stability","volume":"41","author":"D Brambilla","year":"2003","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref026","unstructured":"Carmona S, Seiverth B, Horsfield P, eSa B, Goerdes M, Stevens W. Evaluation of COBAS AmpliPrep\/COBAS TaqMan HIV-1 v2.0 test on dried blood spots. 2011; Rome, Italy: 2011."},{"key":"pmed.1004076.ref027","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/0255-0857.103759","article-title":"Comparison of HIV-1 RNA level estimated with plasma and DBS samples: a pilot study from India (South).","volume":"30","author":"S David","year":"2012","journal-title":"Indian J Med Microbiol"},{"issue":"12","key":"pmed.1004076.ref028","doi-asserted-by":"crossref","first-page":"10361038","DOI":"10.7196\/SAMJ.2015.v105i12.9673","article-title":"Measurement of viral load by the automated Abbott real-time HIV-1 assay using dried blood spots collected and processed in Malawi and Mozambique","volume":"105","author":"F Erba","year":"2015","journal-title":"S Afr Med J"},{"key":"pmed.1004076.ref029","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JCM.03519-13","article-title":"Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 load with the NucliSENS Easy-Q HIV-1 Version 2.0 assay in Malawi","volume":"52","author":"E Fajardo","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/JCM.36.1.258-260.1998","article-title":"Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper","volume":"36","author":"SA Fiscus","year":"1998","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref031","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/JCM.02099-08","article-title":"RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests","volume":"47","author":"C Garrido","year":"2009","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1545109709333111","article-title":"Dried blood spots versus plasma for the quantification of HIV-1 RNA using the manual (PCR-ELISA) Amplicor Monitor HIV-1 Version 1.5 Assay in Yaounde, Cameroon.","volume":"8","author":"G Ikomey","year":"2009","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"pmed.1004076.ref033","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/605502","article-title":"Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania","volume":"49","author":"A Johannessen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"pmed.1004076.ref034","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jviromet.2007.11.011","article-title":"Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal","volume":"148","author":"CT Kane","year":"2008","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jviromet.2008.09.022","article-title":"Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand","volume":"155","author":"W Leelawiwat","year":"2009","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref036","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00705-010-0696-y","article-title":"Genotypic testing for HIV-1 drug resistance using dried blood samples","volume":"155","author":"R Lira","year":"2010","journal-title":"Arch Virol"},{"key":"pmed.1004076.ref037","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/QAD.0b013e328331f702","article-title":"Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities","volume":"23","author":"S Lofgren","year":"2009","journal-title":"AIDS"},{"key":"pmed.1004076.ref038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2008.02116.x","article-title":"Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens","volume":"15","author":"A Marconi","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"pmed.1004076.ref039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0b013e3181aeccbc","article-title":"Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon.","volume":"52","author":"AD Mbida","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.01848-13","article-title":"Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots","volume":"52","author":"S Mercier-Delarue","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref041","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jac\/dkq205","article-title":"Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping","volume":"65","author":"M Monleau","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"pmed.1004076.ref042","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/JCM.02860-13","article-title":"Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia","volume":"52","author":"M Monleau","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref043","unstructured":"Mtapuri-Zinyowera S, Taziwa F, Metcalf C, Mbofana E, De Weerdt S, Flevaud L, et al. Field evaluation of performance of dried blood spots (DBS) from finger-prick for the determination of viral load in a resource-constrained setting in urban and rural Zimbabwe. 7th IAS Conference on HIV Pathogenesis and Treatment and Prevention: Abstract no. TUPE271. Kuala Lumpur, Malaysia; 2013."},{"key":"pmed.1004076.ref044","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0140-6736(03)15103-3","article-title":"Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients","volume":"362","author":"P Mwaba","year":"2003","journal-title":"Lancet"},{"key":"pmed.1004076.ref045","first-page":"956","article-title":"Dried blood spot HIV-1 RNA quantification: a useful tool for viral load monitoring among HIV-infected individuals in India","volume":"136","author":"U Neogi","year":"2012","journal-title":"Indian J Med Res"},{"key":"pmed.1004076.ref046","unstructured":"Ngwende S, Mudenge B, Madzimure D, Mudenge G. Evaluation of the use of dried blood spots for viral load monitoring in resource-limited settings in Zimbabwe. 2012; Washington, DC, USA: 2012."},{"key":"pmed.1004076.ref047","first-page":"75","article-title":"Evaluation of dried blood spots as an alternative sample type in HIV-1 RNA quantification from patients receiving anti-retroviral treatment in Kenya.","volume":"7","author":"E Onkendi","year":"2017","journal-title":"Clin Med Diagn"},{"key":"pmed.1004076.ref048","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/JCM.03048-12","article-title":"Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep\/TaqMan assay, Version 2.0, in Kisumu, Kenya","volume":"51","author":"K Ouma","year":"2013","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref049","doi-asserted-by":"crossref","first-page":"e5475","DOI":"10.1097\/MD.0000000000005475","article-title":"Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification.","volume":"95","author":"P Pannus","year":"2016","journal-title":"Medicine"},{"key":"pmed.1004076.ref050","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/jac\/dkr383","article-title":"Quantification of HIV-RNA from dried blood spots using the Siemens VERSANT(R) HIV-1 RNA (kPCR) assay.","volume":"66","author":"M Pirillo","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"pmed.1004076.ref051","doi-asserted-by":"crossref","first-page":"e0191411","DOI":"10.1371\/journal.pone.0191411","article-title":"Sensitivity and specificity of two dried blood spot methods for HIV-1 viral load monitoring among patients in Hanoi, Vietnam.","volume":"13","author":"T Pollack","year":"2018","journal-title":"PLoS ONE"},{"key":"pmed.1004076.ref052","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jviromet.2009.06.002","article-title":"Quantitation of HIV-1 RNA in dried blood and plasma spots","volume":"161","author":"S Reigadas","year":"2009","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref053","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/cid\/cis015","article-title":"Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy","volume":"54","author":"E Rottinghaus","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pmed.1004076.ref054","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcv.2014.05.005","article-title":"Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.","volume":"60","author":"SE Rutstein","year":"2014","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref055","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1128\/JCM.01569-16","article-title":"Evaluation of the Aptima HIV-1 Quant Dx assay using plasma and dried blood spots","volume":"54","author":"MK Sahoo","year":"2016","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref056","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/JCM.02063-14","article-title":"Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep\/TaqMan HIV-1 Version 2.0","volume":"52","author":"S Sawadogo","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref057","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAI.0000000000001275","article-title":"Field evaluation of dried blood spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: Implications for scale-up in resource-limited settings.","volume":"74","author":"M Schmitz","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref058","first-page":"e01901920","article-title":"First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting","volume":"13","author":"F Taieb","year":"2018","journal-title":"Vietname. PLoS ONE"},{"key":"pmed.1004076.ref059","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcv.2017.05.002","article-title":"HIV-1 viral load measurement in venous blood and fingerprick blood using Abbott RealTime HIV-1 DBS assay.","volume":"92","author":"N Tang","year":"2017","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref060","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1128\/JCM.00176-17","article-title":"A simple phosphate-buffered-saline-based extraction method improves specificity of HIV viral load monitoring using dried blood spots","volume":"55","author":"A Tariro Makadzange","year":"2017","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref061","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jviromet.2005.04.010","article-title":"Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection","volume":"128","author":"S Uttayamakul","year":"2005","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref062","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcv.2009.11.021","article-title":"Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0.","volume":"47","author":"P van Deursen","year":"2010","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref063","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jviromet.2012.02.006","article-title":"Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay","volume":"181","author":"M Vidya","year":"2012","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref064","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e3181edaaf5","article-title":"Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso.","volume":"55","author":"J Viljoen","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e318159d7f4","article-title":"Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy","volume":"46","author":"L Waters","year":"2007","journal-title":"Uganda. J Acquir Immune Defic Syndr"},{"key":"pmed.1004076.ref066","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2015.01.022","article-title":"A simple method to elute cell-free HIV from dried blood spots improves their usefulness for monitoring therapy","volume":"65","author":"X Wu","year":"2015","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref067","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jviromet.2013.07.011","article-title":"Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, C\u00f4te d\u2019Ivoire. The Pedi-Test DBS ANRS 12183 Study","volume":"193","author":"V Yapo","year":"2013","journal-title":"J Virol Methods"},{"key":"pmed.1004076.ref068","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JCM.00425-17","article-title":"Evaluation of the Aptima HIV-1 Quant Dx assay for HIV-1 RNA quantitation in different biological specimen types","volume":"55","author":"C Yek","year":"2017","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref069","doi-asserted-by":"crossref","first-page":"e0179316","DOI":"10.1371\/journal.pone.0179316","article-title":"Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep\/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.","volume":"12","author":"C Zeh","year":"2017","journal-title":"PLoS ONE"},{"key":"pmed.1004076.ref070","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"pmed.1004076.ref071","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.326.7379.41","article-title":"Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative","volume":"326","author":"PM Bossuyt","year":"2003","journal-title":"BMJ"},{"key":"pmed.1004076.ref072","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"PF Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"pmed.1004076.ref073","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a009981","article-title":"Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis","volume":"150","author":"B Takkouche","year":"1999","journal-title":"Am J Epidemiol"},{"key":"pmed.1004076.ref074","article-title":"An empirical assessment of bivariate methods for meta-analysis of test accuracy.","volume":"12","author":"IJ Dahabreh","year":"2012","journal-title":"Methods Research Reports"},{"key":"pmed.1004076.ref075","doi-asserted-by":"crossref","first-page":"e8490","DOI":"10.1371\/journal.pone.0008490","article-title":"Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome","volume":"4","author":"A Pasternak","year":"2009","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"pmed.1004076.ref076","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.jcv.2011.09.015","article-title":"Evolution in the sensitivity of quantitative HIV-1 viral load tests.","volume":"52","author":"BR Cobb","year":"2011","journal-title":"J Clin Virol"},{"key":"pmed.1004076.ref077","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1128\/JCM.00578-12","article-title":"Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation","volume":"50","author":"C Jennings","year":"2012","journal-title":"J Clin Microbiol"},{"key":"pmed.1004076.ref078","author":"World Health Organization","year":"2014","journal-title":"Technical and operational considerations for implementing HIV viral load testing: interim technical update"},{"key":"pmed.1004076.ref079","author":"World Health Organization","year":"2016","journal-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach"},{"key":"pmed.1004076.ref080","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.8096089","article-title":"High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR","volume":"259","author":"M Piatak","year":"1993","journal-title":"Science"},{"key":"pmed.1004076.ref081","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/135965350901400513","article-title":"Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review","volume":"14","author":"RL Hamers","year":"2009","journal-title":"Antivir Ther (Lond)"},{"key":"pmed.1004076.ref082","first-page":"160","article-title":"Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNA","volume":"16","author":"NT Parkin","year":"2014","journal-title":"AIDS Rev"},{"key":"pmed.1004076.ref083","doi-asserted-by":"crossref","first-page":"e86461","DOI":"10.1371\/journal.pone.0086461","article-title":"Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis","volume":"9","author":"P Smit","year":"2014","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004076","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T17:56:05Z","timestamp":1662486965000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004076"}},"subtitle":[],"editor":[{"given":"Marie-Louise","family":"Newell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":83,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004076","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pmed.1004076","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}